Dataset Information

Toward all-day wearable health monitoring: An ultralow-power, reflective organic pulse oximetry sensing patch.

ABSTRACT: Pulse oximetry sensors have been playing a key role as devices to monitor elemental yet critical human health states. Conventional pulse oximetry sensors, however, have relatively large power consumption, impeding their use as stand-alone, continuous monitoring systems that can easily be integrated with everyday life. Here, we exploit the design freedom offered by organic technologies to realize a reflective patch-type pulse oximetry sensor with ultralow power consumption. On the basis of flexible organic light-emitting diodes and organic photodiodes designed via an optical simulation of color-sensitive light propagation within human skin, the proposed monolithically integrated organic pulse oximetry sensor heads exhibit successful operation at electrical power as low as 24 ?W on average. We thereby demonstrate that organic devices not only have form factor advantages for such applications but also hold great promise as enablers for all-day wearable health monitoring systems.

SUBMITTER: Lee H

PROVIDER: S-EPMC6226280 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Toward all-day wearable health monitoring: An ultralow-power, reflective organic pulse oximetry sensing patch.

Lee Hyeonwoo H Kim Eunhye E Lee Yongsu Y Kim Hoyeon H Lee Jaeho J Kim Mincheol M Yoo Hoi-Jun HJ Yoo Seunghyup S

Science advances 20181109 11

Pulse oximetry sensors have been playing a key role as devices to monitor elemental yet critical human health states. Conventional pulse oximetry sensors, however, have relatively large power consumption, impeding their use as stand-alone, continuous monitoring systems that can easily be integrated with everyday life. Here, we exploit the design freedom offered by organic technologies to realize a reflective patch-type pulse oximetry sensor with ultralow power consumption. On the basis of flexib ...[more]

PMID: 30430132

Similar Datasets

Project description:BACKGROUND:Previous results from our trial of early treatment with continuous positive airway pressure (CPAP) versus early surfactant treatment in infants showed no significant difference in the outcome of death or bronchopulmonary dysplasia. A lower (vs. higher) target range of oxygen saturation was associated with a lower rate of severe retinopathy but higher mortality. We now report longer-term results from our prespecified hypotheses. METHODS:Using a 2-by-2 factorial design, we randomly assigned infants born between 24 weeks 0 days and 27 weeks 6 days of gestation to early CPAP with a limited ventilation strategy or early surfactant administration and to lower or higher target ranges of oxygen saturation (85 to 89% or 91 to 95%). The primary composite outcome for the longer-term analysis was death before assessment at 18 to 22 months or neurodevelopmental impairment at 18 to 22 months of corrected age. RESULTS:The primary outcome was determined for 1234 of 1316 enrolled infants (93.8%); 990 of the 1058 surviving infants (93.6%) were evaluated at 18 to 22 months of corrected age. Death or neurodevelopmental impairment occurred in 27.9% of the infants in the CPAP group (173 of 621 infants), versus 29.9% of those in the surfactant group (183 of 613) (relative risk, 0.93; 95% confidence interval [CI], 0.78 to 1.10; P=0.38), and in 30.2% of the infants in the lower-oxygen-saturation group (185 of 612), versus 27.5% of those in the higher-oxygen-saturation group (171 of 622) (relative risk, 1.12; 95% CI, 0.94 to 1.32; P=0.21). Mortality was increased with the lower-oxygen-saturation target (22.1%, vs. 18.2% with the higher-oxygen-saturation target; relative risk, 1.25; 95% CI, 1.00 to 1.55; P=0.046). CONCLUSIONS:We found no significant differences in the composite outcome of death or neurodevelopmental impairment among extremely premature infants randomly assigned to early CPAP or early surfactant administration and to a lower or higher target range of oxygen saturation. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Heart, Lung, and Blood Institute; SUPPORT ClinicalTrials.gov number, NCT00233324.).

Project description:BackgroundCoarctation of the aorta is a common form of critical congenital heart disease that remains challenging to diagnose prior to clinical deterioration. Despite current screening methods, infants with coarctation may present with life-threatening cardiogenic shock requiring urgent hospitalization and intervention. We sought to improve critical congenital heart disease screening by using a novel pulse oximetry waveform analysis, specifically focused on detection of coarctation of the aorta.Methods and resultsOver a 2-year period, we obtained pulse oximetry waveform data on 18 neonates with coarctation of the aorta and 18 age-matched controls hospitalized in the cardiac intensive care unit at Children's Healthcare of Atlanta. Patients with coarctation were receiving prostaglandin E1 and had a patent ductus arteriosus. By analyzing discrete features in the waveforms, we identified statistically significant differences in the maximum rate of fall between patients with and without coarctation. This was accentuated when comparing the difference between the upper and lower extremities, with the lower extremities having a shallow slope angle when a coarctation was present (p-value 0.001). Postoperatively, there were still differences in the maximum rate of fall between the repaired coarctation patients and controls; however, these differences normalized when compared with the same individual's upper vs. lower extremities. Coarctation patients compared to themselves (preoperatively and postoperatively), demonstrated waveform differences between upper and lower extremities that were significantly reduced after successful surgery (p-value 0.028). This screening algorithm had an accuracy of detection of 72% with 0.61 sensitivity and 0.94 specificity.ConclusionsWe were able to identify specific features in pulse oximetry waveforms that were able to accurately identify patients with coarctation and further demonstrated that these changes normalized after surgical repair. Pulse oximetry screening for congenital heart disease in neonates may thus be improved by including waveform analysis, aiming to identify coarctation of the aorta prior to critical illness. Further large-scale testing is required to validate this screening model among patients in a newborn nursery setting who are low risk for having coarctation.

Dataset Information

Toward all-day wearable health monitoring: An ultralow-power, reflective organic pulse oximetry sensing patch.

Publications

Toward all-day wearable health monitoring: An ultralow-power, reflective organic pulse oximetry sensing patch.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure